Compounds > adamantane
Page last updated: 2024-08-21

adamantane and hemantane

adamantane has been researched along with hemantane in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's12 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapitsa, IG; Kovalev, GI; Voronina, TA; Zimin, IA1
Antipova, TA; Kovalev, GI; Logvinov, IO; Zimin, IA1
Kovalev, GI; Salimov, RM1
Ivanova, EA; Kapitsa, IG; Kokshenev, II; Nepoklonov, AV; Val'dman, EA; Voronina, TA2
Alekseev, KV; Bastrygin, DV; Kolyvanov, GB; Litvin, EA; Zherdev, VP1
Ivanova, EA; Kapitsa, IG; Nepoklonov, AV; Val'dman, EA; Voronina, TA1
Kapitsa, IG; Kokshenev, II; Nerobkova, LN; Val'dman, EA; Voronina, TA1
Ivanova, EA; Kapitsa, IG; Val'dman, EA; Voronina, TA1
Antipova, TA; Logvinov, IO; Nepoklonov, AV; Valdman, EA1
Kolik, LG; Nadorova, AV; Seredenin, SB1
Kolik, LG; Konstantinopolsky, MA1

Other Studies

12 other study(ies) available for adamantane and hemantane

ArticleYear
[Effects of subchronic hemantane administration on dopamine and serotonin receptors in intact and MPP+-treated rat brain ex vivo].
    Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Corpus Striatum; Disease Models, Animal; Hippocampus; Male; MPTP Poisoning; Neurotoxins; Parkinson Disease; Parkinson Disease, Secondary; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1

2010
[A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Brain; Dopamine Plasma Membrane Transport Proteins; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Parkinsonian Disorders

2011
[Influence of hemantane and doxycycline on MPTP-evoked behavior violations in C57BL/6 mice].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Animals; Antiparkinson Agents; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Male; Maze Learning; Mice; Mice, Inbred C57BL; Motor Activity; Neurotoxins; Parkinson Disease, Secondary

2011
[Comparative study of amantadine and hemantane effects on development of levodopa-induced dyskinesia in rat model of parkinsonian syndrome].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:7

    Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Benserazide; Disease Models, Animal; Dyskinesia, Drug-Induced; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Substantia Nigra

2011
[Pharmacokinetics of hemantane in rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2011, Volume: 74, Issue:11

    Topics: Adamantane; Animals; Antiparkinson Agents; Biological Availability; Biotransformation; Brain Chemistry; Chromatography, Liquid; Feces; Humans; Injections, Intraperitoneal; Injections, Intravenous; Male; Parkinson Disease; Rats; Rats, Inbred Strains; Tandem Mass Spectrometry; Tissue Distribution

2011
[Study of hemantane effects in rats on a model of early (premotor) stage of Parkinson's disease].
    Eksperimental'naia i klinicheskaia farmakologiia, 2012, Volume: 75, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adamantane; Amantadine; Animals; Antiparkinson Agents; Cognition; Drug Administration Schedule; Male; Neurotoxins; Parkinson Disease, Secondary; Rats; Time Factors

2012
[Effect of hemantane on bioelectric activity of brain in mice with MPTP-induced Parkinson syndrome].
    Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:4

    Topics: Adamantane; Animals; Beta Rhythm; Male; Mice; MPTP Poisoning; Parkinson Disease, Secondary; Theta Rhythm; Time Factors

2013
[Influence of hemantane in injectable dosage form on levodopa-induced dyskinesia in rats with model parkinsonian syndrome].
    Eksperimental'naia i klinicheskaia farmakologiia, 2014, Volume: 77, Issue:5

    Topics: Adamantane; Adrenergic Agents; Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats

2014
Anti-Parkinsonian Activity of Hemantane on a Model of Hemiparkinsonian Syndrome in Rats.
    Bulletin of experimental biology and medicine, 2015, Volume: 159, Issue:3

    Topics: Adamantane; Animals; Antiparkinson Agents; Catalepsy; Levodopa; Male; Rats; Rats, Wistar

2015
[COMPARISON OF CYTOPROTECTIVE EFFECTS OF HEMANTANE AND AMANTADINE UNDER CONDITIONS OF 6-HYDROXYDOPAMINE NEUROTOXIN ACTION ON CULTURED HUMAN NEUROBLASTOMA CELLS].
    Eksperimental'naia i klinicheskaia farmakologiia, 2016, Volume: 79, Issue:1

    Topics: Adamantane; Amantadine; Cell Line, Tumor; Cytoprotection; Dose-Response Relationship, Drug; Humans; Models, Biological; Neuroblastoma; Parkinsonian Disorders

2016
Non-Competitive NMDA Receptor Antagonist Hemantane Reduces Ethanol Consumption in Long-Term Alcohol Experienced Rats.
    Bulletin of experimental biology and medicine, 2017, Volume: 164, Issue:2

    Topics: Adamantane; Alcoholism; Animals; Animals, Outbred Strains; Choice Behavior; Disease Models, Animal; Male; Mice; Mice, Inbred DBA; Motivation; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome

2017
Comparative Assessment of the Effectiveness of Noncompetitive NMDA Receptor Antagonists Amantadine and Hemantane in Morphine Withdrawal Syndrome Model.
    Bulletin of experimental biology and medicine, 2019, Volume: 166, Issue:6

    Topics: Adamantane; Amantadine; Animals; Gene Expression; Hyperalgesia; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Narcotic Antagonists; Rats; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome; Weight Loss

2019